tykhr
sign in
free sign up
Klotho Neurosciences, Inc.
Biotechnology
Healthcare
KLTO
28.51 M shares
NASDAQ US
traded
22 Jul 2025
listed
no
open
1.20
52 week high
2.01
high
1.35
52 week low
0.00
low
1.13
growth
-15.63 %
previous Close
1.36
P/E ratio
market cap
17.65 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
-2.23 M
-8.06 %
eps
0.00 %
-6.42 %
eps surprise
0.00 %
net profit margin
-223398200.00 %
0.00 %
operating incoming
-1.59 M
14.29 %
net change in cash
502 K
3.00 %
cash on hand
566 K
787.76 %
cost of revenue
0.00 %
top